PharmaResearch Co., Ltd. (KOSDAQ:214450)
571,000
-7,000 (-1.21%)
Sep 29, 2025, 1:40 PM KST
PharmaResearch Revenue
PharmaResearch had revenue of 140.61B KRW in the quarter ending June 30, 2025, with 69.19% growth. This brings the company's revenue in the last twelve months to 449.81B, up 51.66% year-over-year. In the year 2024, PharmaResearch had annual revenue of 350.12B with 34.14% growth.
Revenue (ttm)
449.81B
Revenue Growth
+51.66%
P/S Ratio
13.35
Revenue / Employee
999.58M
Employees
450
Market Cap
6,005.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 350.12B | 89.10B | 34.14% |
Dec 31, 2023 | 261.01B | 66.25B | 34.02% |
Dec 31, 2022 | 194.76B | 40.68B | 26.40% |
Dec 31, 2021 | 154.08B | 45.34B | 41.69% |
Dec 31, 2020 | 108.75B | 24.87B | 29.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
LigaChem Biosciences | 148.28B |
HLB Co., Ltd. | 75.57B |